Benefits Of Timely Care In Pancreatic Cancer: A Systematic Review To Navigate Through The Contradictory Evidence
- PMID: 31819622
- PMCID: PMC6875504
- DOI: 10.2147/CMAR.S221427
Benefits Of Timely Care In Pancreatic Cancer: A Systematic Review To Navigate Through The Contradictory Evidence
Abstract
The evidence base of policies that improve the timeliness of cancer care is under ongoing debate. Pancreatic cancer is frequently diagnosed in a stage when curative therapy is not feasible; hence, it is an important target for timelier healthcare interventions. The objectives of our research were to identify all clinical studies on pancreatic cancer care delays via a systematic literature review, to assess the study methodologies for possible biases, to conclude on the available evidence, and to formulate research recommendations on evidence gaps. Nineteen studies were identified and eight reported multivariate analyses. Although many sources of bias shifted the results towards negative or paradoxical findings, a statistically significant association of shorter delays with better clinical outcomes was demonstrated in the majority of studies reporting multivariate analyses. Noninferiority analyses were not published. Further efforts to provide timely care for pancreatic cancer patients are encouraged, and studies on the associations of delay with patient experience and healthcare resource utilization are warranted.
Keywords: bias; delay; pancreatic cancer; prognosis; systematic review; wait time.
© 2019 Lukács et al.
Conflict of interest statement
The employers of the coauthors received public funding for qualitative and quantitative studies on a patient navigation program (OnkoNetwork) from the European Union’s Horizon 2020 Research and Innovation program under Grant Agreement No. 634288 (project acronym: SELFIE). Mr Marcell Csanádi report grants from Syreon Research Institute, during the conduct of the study; Dr Mariann Moizs report grants from Grant Agreement No. 634288 from the EU’s Horizon 2020 Research and Innovation Program, outside the submitted work; Professor Zoltán Kaló report grants from European Union’s Horizon 2020 Research and Innovation program, during the conduct of the study; Professor Zoltán Vokó report other from Syreon Research Institute, outside the submitted work; Dr János György Pitter report grants from European Union’s Horizon 2020 Research and Innovation program, outside the submitted work.
Figures
References
-
- Department of Health, The NHS Cancer Plan. 2000. Available from: http://webarchive.nationalarchives.gov.uk/20130222181549/http://www.dh.g... Accessed June6, 2019.
Publication types
LinkOut - more resources
Full Text Sources